Different effects of fibrates on the microsomal fatty acid chain elongation and the acyl composition of phospholipids in guinea-pigs

被引:12
作者
Vazquez, M [1 ]
Alegret, M [1 ]
Lopez, MC [1 ]
Rodriguez, C [1 ]
Adzet, T [1 ]
Merlos, M [1 ]
Laguna, JC [1 ]
机构
[1] NUCL UNIV PEDRALBES, FAC FARM, DEPT FARMACOL & QUIM TERAPEUT, UNIDAD FARMACOL & FARMACOGNOSIA, E-08028 BARCELONA, SPAIN
关键词
fibrates; elongases; peroxisomal proliferation; microsomal phospholipids; guinea-pigs;
D O I
10.1111/j.1476-5381.1995.tb15144.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects in vitro and in vivo of three fibric acid derivatives, clofibrate (CFB), bezafibrate (BFB) and gemfibrozil (GFB) on some enzyme activities related to fatty acid biosynthesis, namely palmitoyl-CoA synthetase and hydrolases (microsomal and cytosolic), NADH and NADPH cytochrome c reductases and acyl-CoA elongases were investigated in guinea-pigs. 2 The three fibrates inhibited acyl-CoA elongation in vitro, irrespective of the substrate of elongation used (saturated, monounsaturated, polyunsaturated) and with an order of potency GFB>BFB>CFB. In the case of GFB, inhibition occured at concentrations that can be reached in vivo. 3 Microsomal palmitoyl-CoA hydrolase and synthetase were also inhibited in vitro (GFB greater than or equal to BFB>CFB), whereas NADH cytochrome c reductase activity was increased by GFB. Nevertheless, the magnitude of changes were lower than those observed in elongation activities. 4 Treatment with fibrates did not produce peroxisomal proliferation in guinea-pigs, as measured by peroxisomal beta-oxidation activity and liver weight/body weight ratio. Nevertheless, fibrates provoked a reduction in plasma cholesterol and triglycerides, at least in GFB- and BFB-treated animals. 5 Fatty acid elongation was significantly modified by GFB treatment in vivo. The remaining enzyme activities studied were only slightly changed by fibrate treatment. 6 Treatment with BFB and to a lesser extent with CFB, increased the relative proportion of MUFA (palmitoleic and oleic acids) in microsomal phospholipids, whereas PUFA (mainly linoleic acid) decreased. GFB behaved differently, increasing palmitic and linoleic acids and decreasing stearic and oleic acids. The latter changes are attributable to an inhibition of elongation activity by GFB. 7 The changes observed after fibrate treatment in both rats and guinea-pigs, as they are not directly related to peroxisome proliferation, could be more reliably extrapolated to man than those observed only in rats.
引用
收藏
页码:3337 / 3343
页数:7
相关论文
共 34 条
[1]   EFFECT OF SIMVASTATIN AND FENOFIBRATE ON THE FATTY-ACID COMPOSITION OF HYPERCHOLESTEROLEMIC PATIENTS [J].
AGHELI, N ;
JACOTOT, B .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (04) :423-428
[2]   SELECTIVE MODIFICATION OF RAT HEPATIC-MICROSOMAL FATTY-ACID CHAIN ELONGATION AND DESATURATION BY FIBRATES - RELATIONSHIP WITH PEROXISOME PROLIFERATION [J].
ALEGRET, M ;
CERQUEDA, E ;
FERRANDO, R ;
VAZQUEZ, M ;
SANCHEZ, RM ;
ADZET, T ;
MERLOS, M ;
LAGUNA, JC .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (07) :1351-1358
[3]   RELATIONSHIP BETWEEN PLASMA-LIPIDS AND PALMITOYL-COA HYDROLASE AND SYNTHETASE ACTIVITIES WITH PEROXISOMAL PROLIFERATION IN RATS TREATED WITH FIBRATES [J].
ALEGRET, M ;
FERRANDO, R ;
VAZQUEZ, M ;
ADZET, T ;
MERLOS, M ;
LAGUNA, JC .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (02) :551-556
[4]   INVITRO EFFECT OF CLOFIBRIC ACID-DERIVATIVES ON RAT HEPATIC-MICROSOMAL ELECTRON-TRANSPORT CHAINS [J].
ALEGRET, M ;
SANCHEZ, R ;
ADZET, T ;
MERLOS, M ;
LAGUNA, JC .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (10) :2057-2060
[5]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   INDUCTION OF FATTY-ACID BINDING-PROTEIN BY PEROXISOME PROLIFERATORS IN PRIMARY HEPATOCYTE CULTURES AND ITS RELATIONSHIP TO THE INDUCTION OF PEROXISOMAL BETA-OXIDATION [J].
BRANDES, R ;
KAIKAUS, RM ;
LYSENKO, N ;
OCKNER, RK ;
BASS, NM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1034 (01) :53-61
[8]   MODE OF ACTION OF FIBRATES [J].
CATAPANO, AL .
PHARMACOLOGICAL RESEARCH, 1992, 26 (04) :331-340
[10]  
DATO SM, 1972, LIPIDS, V8, P1